IN2012DN01846A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01846A
IN2012DN01846A IN1846DEN2012A IN2012DN01846A IN 2012DN01846 A IN2012DN01846 A IN 2012DN01846A IN 1846DEN2012 A IN1846DEN2012 A IN 1846DEN2012A IN 2012DN01846 A IN2012DN01846 A IN 2012DN01846A
Authority
IN
India
Prior art keywords
isothiozoles
eye
disclosed
treating conditions
treating
Prior art date
Application number
Other languages
English (en)
Inventor
Viswanath Veena
E Donello John
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of IN2012DN01846A publication Critical patent/IN2012DN01846A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1846DEN2012 2009-08-11 2010-08-10 IN2012DN01846A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23304709P 2009-08-11 2009-08-11
PCT/US2010/044946 WO2011019678A1 (en) 2009-08-11 2010-08-10 Isothiozoles for treating conditions of the eye

Publications (1)

Publication Number Publication Date
IN2012DN01846A true IN2012DN01846A (enExample) 2015-08-21

Family

ID=43007053

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1846DEN2012 IN2012DN01846A (enExample) 2009-08-11 2010-08-10

Country Status (11)

Country Link
US (1) US20110039900A1 (enExample)
EP (1) EP2464351A1 (enExample)
JP (1) JP2013501794A (enExample)
KR (1) KR20120081585A (enExample)
CN (1) CN102695505A (enExample)
AU (1) AU2010282698A1 (enExample)
BR (1) BR112012003284A8 (enExample)
CA (1) CA2770894A1 (enExample)
IN (1) IN2012DN01846A (enExample)
RU (1) RU2012105453A (enExample)
WO (1) WO2011019678A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015317531B2 (en) 2014-09-17 2020-11-19 Panoptica, Inc. Ocular formulations for drug-delivery and protection of the anterior segment of the eye
IL251949A0 (en) 2017-04-26 2017-07-31 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Small organic molecules for use in the treatment of neuro-inflammatory diseases
EP3801503A4 (en) 2018-06-07 2021-12-08 Disarm Therapeutics, Inc. INHIBITORS OF SARM1
CA3123215C (en) 2018-12-19 2024-04-02 Disarm Therapeutics, Inc. Inhibitors of sarm1 in combination with neuroprotective agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
US6989451B2 (en) * 2002-06-04 2006-01-24 Valeant Research & Development Heterocyclic compounds and uses thereof
ES2444866T3 (es) * 2004-10-20 2014-02-27 Merck Serono Sa Derivados de 3-arilamino piridina
KR20090033886A (ko) * 2006-07-25 2009-04-06 알콘 리서치, 리미티드 안 질환의 예방 및 치료를 위한 내피 분화 유전자 서브패밀리 3 (edg-3, s1p3) 수용체의 길항제

Also Published As

Publication number Publication date
RU2012105453A (ru) 2013-09-20
CN102695505A (zh) 2012-09-26
US20110039900A1 (en) 2011-02-17
EP2464351A1 (en) 2012-06-20
JP2013501794A (ja) 2013-01-17
WO2011019678A1 (en) 2011-02-17
BR112012003284A2 (pt) 2016-03-01
KR20120081585A (ko) 2012-07-19
BR112012003284A8 (pt) 2016-05-17
AU2010282698A1 (en) 2012-03-15
CA2770894A1 (en) 2011-02-17

Similar Documents

Publication Publication Date Title
PH12012502194A1 (en) Indoles
GB201103062D0 (en) Method
CA2865011C (en) Methods and compositions for treating huntington's disease
IN2011KN03851A (enExample)
MX2011007572A (es) Cubiertas externas reusables para articulos absorbentes para llevar puestos.
MX344786B (es) Composiciones y metodos para tratar enfermedad de gaucher.
EA201171367A1 (ru) Винилиндазолильные соединения
JO3755B1 (ar) تركيبات تستوستيرون
IL216084A0 (en) 2,4-diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
IN2012DN04748A (enExample)
MX359769B (es) Metodos para descelularizar huesos.
IN2012DN04414A (enExample)
GB2498325A (en) Modulation neural pathways
SG173672A1 (en) Novel ortho-aminoamides for the treatment of cancer
GB2482817A (en) Novel use
WO2011047091A9 (en) Methods for treating traumatic brain injury
IL229520A0 (en) Water treatment, especially for obtaining highly purified water
IN2014DN00254A (enExample)
IN2011KN03928A (enExample)
IN2012DN04412A (enExample)
MX2011010046A (es) Derivados de diaminopteridina.
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
AP2011005893A0 (en) Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer.
WO2013009678A3 (en) Compositions and methods for the treatment of norovirus infection
IN2012DN04805A (enExample)